
|Articles|August 6, 2007
New IVIG stored at room temperature
Privigen is indicated for the treatment of both primary immunodeficiency and chronic immune thrombocytopenic purpura and will be launched in the first quarter of 2008.
Advertisement
The first proline-stabilized intravenous immunoglobulin (IVIG) that can be stored at room temperature and does not require reconstitution has been approved by the FDA. Privigen (Immune Globulin Intravenous [Human] 10% Liquid), from CSL Behring, is indicated for the treatment of both primary immunodeficiency and chronic immune thrombocytopenic purpura and will be launched in the first quarter of 2008.
To see more Hot off the Press news articles,
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
3
Pharmacists Want Prescribing Authority With Proper Training, Support
4
What’s Next for Pneumococcal Vaccination? An Expert Weighs In
5






























